-
FDA sets May 2027 decision date on AMT-130 gene therapy for HD
4 min read
Latest News
-
A recycled drug gives us new insight in to HD
7 min read
An existing drug could give a boost to HD brain cells – but it may need more testing before it’s back in the clinic
-
Through the eyes of a friend: changes in mood and behavior in early HD
8 min read
Companions of HD gene carriers are more likely to notice psychological changes in presymptomatic HD.
-
A multiple sclerosis drug that works for Huntington's disease: the real deal or too good to be true?
8 min read
Fingolimod, a drug used in multiple sclerosis, prevents memory problems in HD mice. Would it work in patients?
-
Mapping the anatomy of HD: a whole-brain history
10 min read
A new book for researchers describes a century of HD anatomy and presents evidence that HD affects the whole brain.
-
Liftoff: First humans treated with gene silencing drugs for HD!
8 min read
Major Announcement: First HD patients treated with gene silencing drugs
-
HDBuzz primer: Clinical trial designs and phases
17 min read
HDBuzz untangles hope from hype in clinical trial announcements
-
A Few Bad Seeds: Using Brain Fluid to Grow Clumps in Brain Cells
7 min read
HD brain fluid makes brain cells grow clumps.
-
New tool to measure outcomes in Huntington’s Disease clinical trials
6 min read
A better tool for HD trials! New research shows innovative way to measure mutant Huntingtin outside the brain
-
Huge study reveals new 'genetic modifiers' of Huntington's disease
8 min read
GeM-HD identifies the first solid leads in the hunt for genetic variations that affect Huntington's disease onset
-
Would ewe believe it? GM1, sheep and Huntington's disease
8 min read
HD researchers and sheep farmers are collaborating on a brain fat called GM1, but a clinical trial is a long way off
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
